The International Leaders in Community Oncology Research

At The START Center for Cancer Research, our mission is to accelerate the development of new anticancer drugs that will improve the quality of life and survival for patients with cancer and lead to its eventual cure.

Play Video
Play Video
Drugs to Market
of SQFT. Research Facilities
0 K+
Active Studies
Active Patients
0 +
Our Principal Investigators

Global Team of 25 Investigators

The world’s largest collection of early phase Principal Investigators and highly skilled research and operational staff.


The START oncology research centers: 100,000+ square feet of world-class research facilities

START San Antonio

The cornerstone of START’s network with 13,000+ sq. feet of space, 4 dedicated PIs, 60+ clinical research staff, and home to our global shared services team.

START Midwest

Our Grand Rapids, MI, site now has 5 PIs, including specialists in hematology and gynecologic oncology. With 19,000+ sq. feet of space and 50+ clinical research staff, the site is a premier location for early phase research.

START Mountain Region

Situated in a brand new outpatient building with 11,000+ sq. feet of space, our Mountain Region site boasts a dedicated early phase program and over 200 patients enrolled to date on early phase studies.


START CIOCC was the first START site in the European Union. Currently, they enroll 275+ patients annually on more than 150 open early-phase studies, making it one of the top-enrolling centers in the EU.

START Madrid – FJD

START Madrid FJD is the first research facility to be located within a public teaching hospital in Europe. The site includes 5 PIs, over 60+ clinical research staff, and a dedicated hematologic malignancies research team.

START Barcelona

Located within a newly renovated dedicated research space of ~3,500+ sq. feet of space, this site has a strong infrastructure to provide opportunities for patients to participate in cutting-edge research.

START Lisbon

With state-of-the-art facilities, a dedicated early phase team, and tremendous patient access, START Lisbon is poised to contribute significantly to START’s mission of providing trials to communities globally.

START Dublin

As the first dedicated early phase center in the Republic of Ireland, this site is committed to advancing early-phase oncology trials by greatly enhancing patient access and availability.

Our Studies

An established track record of success

In our work with leading biopharma sponsors, CROs, physicians, and patients, we bring cutting-edge research to the community setting and have done so for the past two decades.

Expertise Across All Cancers

Including solid tumors and hematologic malignancies

Regularly First to Enroll

95% of the time, we are the first site to open

Access to Global Patient Population

30,000 new patients annually

Strong Record of Compliance

No findings over 150 audits over 15 years

Our Unique Value

A fully centralized global network of sites

Our integrated process across the START network seamlessly combines the expertise of our investigators to support your protocol design, leveraging our extensive patient databases to strategically place your trial at our sites. We centralize the coordination of contract, budget, and IRB review across all locations, managing regulatory documents efficiently.

With a single point of contact and consistent standard operating procedures (SOPs) and protocols for study conduct across all sites, we ensure streamlined and consistent management of your trial, optimizing efficiency and quality throughout the research process.

Clinical Trials

Explore our Clinical Trials

If you are interested in participating in a clinical trial at The START Center, we encourage you to reach out to us. Our team will guide you through the process, answer any questions you may have, and help determine if you are eligible for any ongoing trials.

Our Brands